Hui-Fen Liao

Title: Innovations by Inventor Hui-Fen Liao

Introduction

Hui-Fen Liao is a notable inventor based in Chiayi, Taiwan. He has made significant contributions to the field of medicine, particularly in the treatment of cancer. With a total of four patents to his name, Liao's work focuses on innovative methods and compounds that have the potential to improve patient outcomes.

Latest Patents

Among his latest patents is the invention of lipophilic N-substituted norcantharimide derivatives. These novel compounds are disclosed as useful lead compounds for manufacturing medicaments or pharmaceutical compositions aimed at treating cancer, especially leukemia. Another significant patent involves a method of treating leukemia using rice prolamin. This method comprises administering a daily dose of isolated prolamin to patients suffering from leukemia over a period of 5 to 10 days. The rice prolamin can stimulate human peripheral blood mononuclear cells to produce cytokines, such as tumor necrosis factor-alpha, which inhibit the growth of and induce differentiation in human leukemia cells. Notably, the rice prolamin is gluten-free, minimizing the risk of gastrointestinal allergic reactions while effectively decreasing tumor weight without affecting body weight.

Career Highlights

Hui-Fen Liao has worked at prominent institutions such as Mackay Memorial Hospital and Taipei Veterans General Hospital. His experience in these hospitals has allowed him to apply his research in practical settings, contributing to advancements in cancer treatment.

Collaborations

Liao has collaborated with notable colleagues, including Yu-Jen Chen and Cheng-Deng Kuo. These partnerships have likely enhanced the scope and impact of his research.

Conclusion

Hui-Fen Liao's innovative work in cancer treatment through his patents demonstrates his commitment to improving healthcare outcomes. His contributions are paving the way for new therapeutic approaches in the fight against leukemia.